Literature DB >> 31970653

The Effects of Sclerostin on the Immune System.

Cristine Donham1, Jennifer O Manilay2,3.   

Abstract

PURPOSE OF REVIEW: We reviewed recent progress on the role of sclerostin (SOST) and its effects on the immune system in order to summarize the current state of knowledge in osteoimmunology, in regard to hematopoiesis, lymphopoiesis, and inflammation. RECENT
FINDINGS: Changes in sclerostin levels affect distinct niches within the bone marrow that support hematopoietic stem cells and B cell development. Sclerostin's regulation of adipogenesis could also be important for immune cell maintenance with age. Surprisingly, B cell development in the bone marrow is influenced by Sost produced by mesenchymal stem cells and osteoblasts, but not by osteocytes. Additionally, extramedullary hematopoiesis in the spleen and increased pro-inflammatory cytokine levels in the bone marrow are observed in global Sost-/- mice. In addition to changes in bone marrow density, sclerostin depletion affects B lymphopoiesis and myelopoiesis, as well as other changes within the bone marrow cavity that could affect hematopoiesis. It is therefore important to monitor for hematopoietic changes in patients receiving sclerostin-depleting therapies.

Entities:  

Keywords:  Cell differentiation; Hematopoiesis; Immunology; Osteoimmunology; Wnt; Wnt antagonists

Mesh:

Substances:

Year:  2020        PMID: 31970653     DOI: 10.1007/s11914-020-00563-w

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  45 in total

1.  The haematopoietic stem cell niche at a glance.

Authors:  Cristina Lo Celso; David T Scadden
Journal:  J Cell Sci       Date:  2011-11-01       Impact factor: 5.285

Review 2.  Hematopoietic stem cell fate decisions are regulated by Wnt antagonists: comparisons and current controversies.

Authors:  Corey J Cain; Jennifer O Manilay
Journal:  Exp Hematol       Date:  2012-09-25       Impact factor: 3.084

3.  Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches.

Authors:  Lei Ding; Sean J Morrison
Journal:  Nature       Date:  2013-02-24       Impact factor: 49.962

4.  Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers.

Authors:  Antoon H van Lierop; Neveen A T Hamdy; Martje E van Egmond; Egbert Bakker; Freek G Dikkers; Socrates E Papapoulos
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

5.  Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo.

Authors:  Heather E Fleming; Viktor Janzen; Cristina Lo Celso; Jun Guo; Kathleen M Leahy; Henry M Kronenberg; David T Scadden
Journal:  Cell Stem Cell       Date:  2008-03-06       Impact factor: 24.633

Review 6.  Origin and physiological roles of inflammation.

Authors:  Ruslan Medzhitov
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

7.  Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study.

Authors:  Michael R McClung; Jacques P Brown; Adolfo Diez-Perez; Heinrich Resch; John Caminis; Paul Meisner; Michael A Bolognese; Stefan Goemaere; Henry G Bone; Jose R Zanchetta; Judy Maddox; Sarah Bray; Andreas Grauer
Journal:  J Bone Miner Res       Date:  2018-05-22       Impact factor: 6.741

8.  Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.

Authors:  Xiaodong Li; Michael S Ominsky; Qing-Tian Niu; Ning Sun; Betsy Daugherty; Diane D'Agostin; Carole Kurahara; Yongming Gao; Jin Cao; Jianhua Gong; Frank Asuncion; Mauricio Barrero; Kelly Warmington; Denise Dwyer; Marina Stolina; Sean Morony; Ildiko Sarosi; Paul J Kostenuik; David L Lacey; W Scott Simonet; Hua Zhu Ke; Chris Paszty
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

9.  HIF-1α inhibits Wnt signaling pathway by activating Sost expression in osteoblasts.

Authors:  Dafu Chen; Yang Li; Zhiyu Zhou; Chengai Wu; Yonggang Xing; Xuenong Zou; Wei Tian; Chi Zhang
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

10.  Distinctive Mesenchymal-Parenchymal Cell Pairings Govern B Cell Differentiation in the Bone Marrow.

Authors:  Vionnie W C Yu; Stefania Lymperi; Toshihiko Oki; Alexandra Jones; Peter Swiatek; Radovan Vasic; Francesca Ferraro; David T Scadden
Journal:  Stem Cell Reports       Date:  2016-07-21       Impact factor: 7.765

View more
  6 in total

1.  Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs.

Authors:  Alvaro Del Real; Sergio Ciordia; Carolina Sañudo; Carmen Garcia-Ibarbia; Adriel Roa-Bautista; Javier G Ocejo-Viñals; Fernando Corrales; Jose A Riancho
Journal:  Metabolites       Date:  2022-04-28

Review 2.  Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones.

Authors:  Jialiang S Wang; Courtney M Mazur; Marc N Wein
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-10       Impact factor: 5.555

Review 3.  The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research.

Authors:  Meiheng Sun; Zihao Chen; Xiaoqiu Wu; Yuanyuan Yu; Luyao Wang; Aiping Lu; Ge Zhang; Fangfei Li
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

4.  Blood protein profiles related to preterm birth and retinopathy of prematurity.

Authors:  Hanna Danielsson; Abdellah Tebani; Wen Zhong; Linn Fagerberg; Nele Brusselaers; Anna-Lena Hård; Mathias Uhlén; Ann Hellström
Journal:  Pediatr Res       Date:  2021-04-24       Impact factor: 3.953

Review 5.  The Emerging Role of Bone-Derived Hormones in Diabetes Mellitus and Diabetic Kidney Disease.

Authors:  Yixuan Li; Zuhua Gu; Jun Wang; Yangang Wang; Xian Chen; Bingzi Dong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-11       Impact factor: 6.055

Review 6.  B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Rick Wilbrink; Anneke Spoorenberg; Gwenny M P J Verstappen; Frans G M Kroese
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.